Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 7:28:e936571.
doi: 10.12659/MSM.936571.

Retracted: The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib

Hao Song  1 , Jinna Zhang  2 , Liang Ning  3 , Honglai Zhang  2 , Dong Chen  3 , Xuelong Jiao  3 , Kejun Zhang  2
Affiliations

Retracted: The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib

Hao Song et al. Med Sci Monit. .

Abstract

This publication has been retracted by the Editor due to the identification of falsified figure images and manuscript content that raise concerns regarding the credibility of the study and the manuscript. Reference: Vemurafenib Hao Song, Jinna Zhang, Liang Ning, Honglai Zhang, Dong Chen, Xuelong Jiao, Kejun Zhang. The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib. Med Sci Monit, 2018; 24: 3002-3010. DOI: 10.12659/MSM.910084.

PubMed Disclaimer

Retraction of

Similar articles

See all similar articles

References

    1. Song Vemurafenib Hao, Zhang Jinna, Ning Liang, Zhang Honglai, Chen Dong, Jiao Xuelong, Zhang Kejun. The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib. Med Sci Monit. 2018;24:3002–3010. doi: 10.12659/MSM.910084. - DOI - PMC - PubMed

Publication types